New business, strategic acquisitions, geographic diversification, solid customer retention levels and a strong capital position poise Willis Towers (WTW) for growth.
LONDON, June 27, 2024 (GLOBE NEWSWIRE) -- 63% of life science companies believe the high cost of new drug development is among the emerging themes that will have the greatest negative impact on the sector in the next 3-5 years, according to Global life science risk report 2024 published today by WTW (NASDAQ: WTW), a leading global advisory, broking, and solutions company. This is leading to an increased focus on finding novel use cases for existing drugs, named by 66% as having a positive impact
NEW YORK, June 25, 2024 (GLOBE NEWSWIRE) -- WTW (NASDAQ: WTW), a leading global advisory, broking, and solutions company, today announced the appointment of three strategic new hires within the Financial Institutions and Professional Services industry division, which is part of Corporate Risk and Broking, North America (CRB NA). Bringing deep expertise within broker-dealers and independent financial advisors, the addition of Heather Mann, Larry Trombino, and Jeanette Younger will significantly b